Board of Directors

GMO’s Board of Directors represents a balance of different backgrounds, cultures, and work and life experiences.

Drawing on their areas of expertise, the Board provides advice and counsel to the CEO and other firm leaders for the benefit of successfully implementing GMO’s strategy and delivering exceptional value to clients.

Steve Casper

Stephen Casper

Mr. Casper is a member of the GMO Board of Directors. He has more than thirty years’ experience in the financial services industry which includes senior leadership roles at The Rohatyn Group, Vastardis Capital Services, Fischer Francis Trees & Watts, Inc., and the Rockefeller Family Office. He is currently the Lead Independent Director at MarketAxess Holdings and serves on the Boards of the KLS Funds, CaringKind, a charity focused on support services for the Alzheimer’s community in New York City, and the Brooklyn Museum, where he is also a member of the Investment Committee. He was previously on the Board of the Depository Trust and Clearing Corporation. Mr. Casper holds a B.B.A. from Baruch College of the City University of New York and an M.S. in Finance and Accounting from the Wharton School of Business. 

Jeremy Grantham

Jeremy Grantham

Long-Term Investment Strategist, Co-Founder

Mr. Grantham co-founded GMO in 1977 and is a member of GMO’s Asset Allocation team, serving as the firm’s long-term investment strategist. He is the Chairman of the GMO Board of Directors, a partner of the firm, and has also served on the investment boards of several non-profit organizations. Prior to GMO’s founding, Mr. Grantham was co-founder of Batterymarch Financial Management in 1969 where he recommended commercial indexing in 1971, one of several claims to being first. He began his investment career as an economist with Royal Dutch Shell. Mr. Grantham earned his undergraduate degree from the University of Sheffield (U.K.) and an MBA from Harvard Business School. He is a member of the Academy of Arts and Sciences, holds a CBE from the UK and is a recipient of the Carnegie Medal for Philanthropy.

Scott Hayward

Scott Hayward

Chief Executive Officer

Mr. Hayward is the Chief Executive Officer of GMO, a member of the GMO Board of Directors and a partner of the firm. Prior to joining GMO in 2017, he served as the Chief Executive Officer and Chairman of Quantitative Management Associates LLC (QMA) for 11 years. Previously, he was the Head of Client Relations at QMA and Jennison Associates (both affiliates of Prudential Financial, Inc.). Prior to joining QMA and Jennison Associates in 2003, Mr. Hayward served as Managing Director, Head of Institutional Client Services and Marketing at J.P. Morgan Asset Management. Prior to that, he was a Vice President and served in a variety of roles in the investment bank, private bank, and corporate divisions at J.P. Morgan & Co. Mr. Hayward earned his bachelor's degree in Political Science from Boston College.

Broker check


Anthony Hene

Portfolio Manager

Mr. Hene is a portfolio manager for GMO’s Quality Strategies and a member of the Focused Equity team. He is also a member of the GMO Board of Directors and a partner of the firm. Previously at GMO, he was engaged in portfolio management within the Global Equity team. Mr. Hene joined GMO full-time in 1995. He has an MSc in Biochemistry from the University of Oxford and is a CFA charterholder.


Ben Inker

Co-Head of Asset Allocation

Mr. Inker is co-head of GMO’s Asset Allocation team, a member of the GMO Board of Directors and a partner of the firm. He joined GMO in 1992 following the completion of his bachelor's degree in Economics from Yale University. In his years at GMO, Mr. Inker has served as an analyst for the Quantitative Equity and Asset Allocation teams, as a portfolio manager of several equity and asset allocation portfolios, as co-head of International Quantitative Equities, and as CIO of Quantitative Developed Equities. He is a CFA charterholder.


Peg McGetrick

Ms. McGetrick is a member of the GMO Board of Directors. Previously, Ms. McGetrick was a founding partner of Liberty Square Asset Management and portfolio manager. In her previous employment with GMO from 1984 to 1996, she was a portfolio manager on the International Active Equity team and was also partner of the firm from 1988 through 1997. Ms. McGetrick began her investment career in non-US equities in 1982 as an analyst for The Commonfund for International Investments. She currently serves on the Board of Save the Children, where she is also chair of the Investment Committee, and formerly served on the Investment Committees of Partners Healthcare System, Providence College, and The Wheeler School. Ms. McGetrick graduated from Providence College with a bachelor's degree in Psychology and Business Management and a MS in Finance from Fairfield University.


Andrea Muller

Ms. Muller is a member of the GMO Board of Directors. She is an experienced CEO and financial services executive with a diverse global background in asset management, credit rating, investment banking, and law in addition to significant Board and working experience with investment boutiques. She spent most of her career outside of the U.S., including 15 years in Asia and 10 years in Europe, in addition to 8 years in the U.S. Ms. Muller currently serves as a Non-Executive Director on the Board of Directors at Burford Capital Limited and on Advisory Boards for Forward Risk and Intelligence and the Business Law Scholars Program at Georgetown University Law Center. Previously, she was a member of the Operating Committee for Principal Global Investors, including as CEO of Asia and Global Head of Institutional Business. Prior to that, she was Head of Asia-Pacific for Fitch Ratings and Managing Director at UBS in both France and Singapore specializing in capital markets and institutional asset management sales. Ms. Muller began her career at Shearman & Sterling, where she was a European partner and worked as a corporate lawyer in both New York and Paris. She has a B.S. from Georgetown University School of Foreign Service, a Masters in European Union Studies from the College of Europe in Belgium, and a J.D. from Georgetown Law Center.


Mark Nitzberg

Dr. Nitzberg is a member of the GMO Board. He has more than twenty-five years' experience founding, managing, and advising technology-oriented companies. Dr. Nitzberg is currently Executive Director of the Center for Human-Compatible Artificial Intelligence and Head of Strategic Outreach for Berkeley Artificial Intelligence Research at the University of California, Berkeley. He also currently serves in advisory, board, and other executive roles for DM Group, Grabango, Akvo Foundation USA, Spoondrift Technologies, and Cambrian Group. Previously, he was Director of Computer Vision Products at A9, an Amazon subsidiary focused on search engine and search advertising technology, following Amazon’s acquisition of The Blindsight Corporation, where Dr. Nitzberg was the founding CEO. Prior to that, he co-founded Smartleaf, a provider of automated portfolio rebalancing and tax optimization solutions for wealth managers, RIAs, broker-dealers, and banks. He also co-founded RapidCare, Inc., and served in leadership roles at Viaweb. Dr. Nitzberg earned his B.A. in Mathematics and Music Composition from the University of Oregon and his Ph.D. in Computer Science from Harvard University.